Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

I-Mab ADR (IMAB)

I-Mab ADR (IMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

I-Mab ADR SUITE 400 2440 RESEARCH BLVD ROCKVILLE MD 20850 CHN

www.i-mabbiopharma.com/en P: 240-745-6330

Description:

I-Mab is a clinical stage biopharmaceutical company. It engages in discovery, development and commercialization of biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab is based in SHANGHAI, China.

Key Statistics

Overview:

Market Capitalization, $K 143,163
Enterprise Value, $K -154,237
Shares Outstanding, K 80,883
Annual Sales, $ 3,890 K
Annual Net Income, $ -206,440 K
Last Quarter Sales, $ 1,543 M
Last Quarter Net Income, $ 1,042 M
EBIT, $ 0 K
EBITDA, $ -166,660 K
60-Month Beta 1.10
% of Insider Shareholders 22.10%
% of Institutional Shareholders 38.38%
Float, K 63,008
% Float 77.90%
Short Volume Ratio 0.44

Growth:

1-Year Return -47.60%
3-Year Return -97.43%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 03/29/24
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr 2,155.96%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IMAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -5,306.94%
Debt/Equity 0.02
Price/Sales 37.81
Price/Cash Flow N/A
Price/Book 0.63
Book Value/Share 2.93
Interest Coverage -2,063.40
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar